Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Neuromolecular Medicine
|
September 21, 2016
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
Pashtun Shahim, Kaj Blennow, Per Johansson, et al.
Endocrine Connections
|
November 15, 2023
Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men
Henrik Ryberg, Anna-Karin Norlén, Andreas Landin, et al.
Plos One
|
May 3, 2017
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
December 24, 2011
Achieving reliable communication in dynamic emergency responses
Octav Chipara, Anders N Plymoth, Fang Liu, et al.
Neuroscience Letters
|
October 11, 2015
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
Journal of Diabetes and Its Complications
|
April 9, 2016
Reduced brachial artery distensibility in patients with type 1 diabetes
Philip Ljunggren, David M Maahs, Per Johansson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population
Per Johansson, Niklas Mattsson, Oskar Hansson, et al.
Experimental Gerontology
|
January 3, 2012
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study
Sofia Movérare-Skrtic, Per Johansson, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson, Erik G Almqvist, Maria Bjerke, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
Karolina Minta, Gunnar Brinkmalm, Erik Portelius, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Neuromolecular Medicine
|
September 21, 2016
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
Pashtun Shahim, Kaj Blennow, Per Johansson, et al.
Endocrine Connections
|
November 15, 2023
Sex steroid levels in corresponding cerebrospinal fluid and serum samples quantified by mass spectrometry in men
Henrik Ryberg, Anna-Karin Norlén, Andreas Landin, et al.
Plos One
|
May 3, 2017
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
December 24, 2011
Achieving reliable communication in dynamic emergency responses
Octav Chipara, Anders N Plymoth, Fang Liu, et al.
Neuroscience Letters
|
October 11, 2015
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Per Johansson, Erik G Almqvist, Anders Wallin, et al.
Journal of Diabetes and Its Complications
|
April 9, 2016
Reduced brachial artery distensibility in patients with type 1 diabetes
Philip Ljunggren, David M Maahs, Per Johansson, et al.
Journal of Alzheimer'S Disease : JAD
|
February 8, 2011
Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population
Per Johansson, Niklas Mattsson, Oskar Hansson, et al.
Experimental Gerontology
|
January 3, 2012
Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study
Sofia Movérare-Skrtic, Per Johansson, Niklas Mattsson, et al.
Journal of Alzheimer'S Disease : JAD
|
July 13, 2017
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson, Erik G Almqvist, Maria Bjerke, et al.
Journal of Alzheimer'S Disease : JAD
|
December 18, 2020
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
Karolina Minta, Gunnar Brinkmalm, Erik Portelius, et al.
Page
of 9